This significantly increases the risk of severe gastrointestinal distress
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017
Appropriate candidates for exploratory GLP-1 treatment with attention to mood/attention benefits typically have weight-related comorbidities, adequate psychiatric stability on current regimens, and realistic expectations about limited evidence
These typically resolve within 24-48 hours without intervention
1 ng/0.1 ml saline/each eye) is given at either 20 min after L-NAME or, lately, at 48 h after L-NAME, the regular retrobulbar L-NAME injection findings disappear
For example, a percent use requirement can be added to confirm a patient has utilized most of their existing supply of a GLP-1 prior to issuing an automated PA approval